“…These data suggest that the immunological effects of SSRIs are more favorable in subjects who had jeopardized immune responses concomitantly with psychiatric symptoms. Furthermore, inpatients usually suffer from more serious depressive symptoms than outpatients and thus are more likely to offer a better immunological response, under appropriate treatment, than outpatients (Carrillo-Jimenez et al, 2001). Similarly, severe depressive episodes, unlike those of moderate degrees, present a better response to the antidepressant treatment.…”